Weaver C. Barksdale & Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$5K	Buy	117 +23	+24%	+$1.05K	0.01%	372
2017 Q3	$5K	Buy	94 +5	+6%	+$255	0.01%	372
2017 Q2	$5K	Sell	89 -6	-6%	-$322	0.01%	377
2017 Q1	$5K	Hold	95	–	–	0.01%	385
2016 Q4	$5K	Buy	95 +11	+13%	+$531	0.01%	380
2016 Q3	$4K	Buy	84 +16	+24%	+$809	0.01%	402
2016 Q2	$4K	Buy	+68	New	+$3.75K	0.01%	391

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MRCP

Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Weaver C. Barksdale & Associates's PBH Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Prestige Consumer Healthcare (PBH) stake by 24% in Q4 2017, buying an estimated $1.05K and bringing the position to 117 shares worth $5K. The position accounts for 0.01% of the portfolio, ranked #372.

Weaver C. Barksdale & Associates first reported a position in PBH in Q2 2016 and has held it in 7 quarters since. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

Weaver C. Barksdale & Associates held 117 shares of Prestige Consumer Healthcare worth $5K as of Q4 2017.
Weaver C. Barksdale & Associates bought 23 Prestige Consumer Healthcare shares in Q4 2017, an estimated $1.05K.
Prestige Consumer Healthcare made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #372 holding.
Weaver C. Barksdale & Associates first reported a position in Prestige Consumer Healthcare in Q2 2016 and has held it in 7 quarters since.
251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.